Updated Date: Thu, 05 Sep 2024 00:00:00 EDT
Vous n'êtes pas connecté
GAITHERSBURG, Md., Aug. 30, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula)...
Updated Date: Thu, 05 Sep 2024 00:00:00 EDT
Though Novavax is behind in the COVID-19 vaccine race, a blockbuster deal with Sanofi and a differentiated product means the stock offers the best...
Updated Date: Wed, 18 Sep 2024 00:00:00 EDT
TORONTO — Health Canada has authorized Moderna's updated COVID-19 vaccine that protects against currently circulating variants of the virus.
TORONTO - Health Canada has authorized Moderna's updated COVID-19 vaccine that protects against currently circulating variants of the virus. The mRNA...
TORONTO - Health Canada has authorized Moderna's updated COVID-19 vaccine that protects against currently circulating variants of the virus. The mRNA...
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
TORONTO — Health Canada authorized Moderna's updated COVID-19 vaccine that protects against currently circulating variants of the virus on Tuesday....
TORONTO — Health Canada authorized Moderna's updated COVID-19 vaccine that protects against currently circulating variants of the virus on Tuesday....
Novavax and Alnylam are in the spotlight following drug approval and regulatory updates, respectively.